EP 4281054 A1 20231129 - NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF FOR THE TREATMENT OF VIRAL DISEASES
Title (en)
NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF FOR THE TREATMENT OF VIRAL DISEASES
Title (de)
NEUARTIGE VERBINDUNGEN ZUR MODULATION DES ZELLMETABOLISMUS UND VERWENDUNGEN DAVON ZUR BEHANDLUNG VON VIRENERKRANKUNGEN
Title (fr)
NOUVEAUX COMPOSÉS MODULANT LE MÉTABOLISME CELLULAIRE ET LEURS UTILISATIONS POUR LE TRAITEMENT DE MALADIES VIRALES
Publication
Application
Priority
- US 202063048619 P 20200706
- US 2021040584 W 20210706
Abstract (en)
[origin: WO2022010948A1] A class of compounds that bind to FABP4 and inhibit viral replication in cells, as well as pharmaceutical compositions comprising the class of compounds, in combination with a pharmaceutically acceptable diluent or carrier, and optionally, further in combination with an additional therapeutically active agent, and the use of these compounds in medicine and for the preparation of a medicament in the treatment of viral diseases. Formula I
IPC 8 full level
A61K 31/122 (2006.01); A61K 31/15 (2006.01); A61K 31/194 (2006.01)
CPC (source: EP)
A61P 31/14 (2017.12); C07D 215/227 (2013.01); C07D 215/38 (2013.01); C07D 215/48 (2013.01); C07D 401/04 (2013.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01); C07D 413/04 (2013.01); C07D 417/06 (2013.01)
Citation (search report)
See references of WO 2022010948A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2022010948 A1 20220113; CN 116615189 A 20230818; EP 4281054 A1 20231129; JP 2023532998 A 20230801
DOCDB simple family (application)
US 2021040584 W 20210706; CN 202180054153 A 20210706; EP 21838930 A 20210706; JP 2023500381 A 20210706